KR101622524B1 - 안정한 펙시가난 제제 - Google Patents

안정한 펙시가난 제제 Download PDF

Info

Publication number
KR101622524B1
KR101622524B1 KR1020157000319A KR20157000319A KR101622524B1 KR 101622524 B1 KR101622524 B1 KR 101622524B1 KR 1020157000319 A KR1020157000319 A KR 1020157000319A KR 20157000319 A KR20157000319 A KR 20157000319A KR 101622524 B1 KR101622524 B1 KR 101622524B1
Authority
KR
South Korea
Prior art keywords
surfactant
hydrophilic
formulation
hydrophobic
tween
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020157000319A
Other languages
English (en)
Korean (ko)
Other versions
KR20150043286A (ko
Inventor
나얀 데사이
Original Assignee
디펙시움 파마슈티컬스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디펙시움 파마슈티컬스, 인크. filed Critical 디펙시움 파마슈티컬스, 인크.
Publication of KR20150043286A publication Critical patent/KR20150043286A/ko
Application granted granted Critical
Publication of KR101622524B1 publication Critical patent/KR101622524B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020157000319A 2012-06-12 2013-06-10 안정한 펙시가난 제제 Expired - Fee Related KR101622524B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/494,295 2012-06-12
US13/494,295 US8530409B1 (en) 2012-06-12 2012-06-12 Stable pexiganan formulation
PCT/US2013/044957 WO2013188286A1 (en) 2012-06-12 2013-06-10 Stable pexiganan formulation

Publications (2)

Publication Number Publication Date
KR20150043286A KR20150043286A (ko) 2015-04-22
KR101622524B1 true KR101622524B1 (ko) 2016-05-18

Family

ID=49084089

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157000319A Expired - Fee Related KR101622524B1 (ko) 2012-06-12 2013-06-10 안정한 펙시가난 제제

Country Status (26)

Country Link
US (2) US8530409B1 (https=)
EP (1) EP2858721B1 (https=)
JP (1) JP5876191B2 (https=)
KR (1) KR101622524B1 (https=)
CN (1) CN104602762B (https=)
AU (1) AU2013274561B2 (https=)
BR (1) BR112014030993A2 (https=)
CA (1) CA2876668C (https=)
CY (1) CY1118277T1 (https=)
DK (1) DK2858721T3 (https=)
EA (1) EA028002B1 (https=)
ES (1) ES2599395T3 (https=)
HR (1) HRP20161440T1 (https=)
HU (1) HUE030665T2 (https=)
IL (1) IL236151A (https=)
LT (1) LT2858721T (https=)
MX (1) MX345263B (https=)
NZ (1) NZ703176A (https=)
PL (1) PL2858721T3 (https=)
PT (1) PT2858721T (https=)
RS (1) RS55286B1 (https=)
SG (1) SG11201408055PA (https=)
SI (1) SI2858721T1 (https=)
SM (1) SMT201600411B (https=)
WO (1) WO2013188286A1 (https=)
ZA (1) ZA201500117B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
GB201505393D0 (en) * 2015-03-30 2015-05-13 Secr Defence Antimicrobal peptide formulations
CN111925430B (zh) * 2020-08-18 2022-05-24 中国海洋大学 抗菌肽及其应用
US20230106943A1 (en) * 2021-09-17 2023-04-06 Peptilogics, Inc. Engineered antimicrobial peptides and usage thereof
KR102773934B1 (ko) * 2021-11-25 2025-02-26 광주여자대학교 산학협력단 Msi-78 펩타이드를 유효성분으로 포함하는 항균용 화장료 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100036000A1 (en) 2008-07-21 2010-02-11 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US20100221195A1 (en) 2006-11-14 2010-09-02 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4169703A (en) * 1978-08-03 1979-10-02 Syntex (U.S.A.) Inc. Oxidative red hair dye
US5912231A (en) * 1989-07-07 1999-06-15 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
AU2005221427B2 (en) * 2004-03-18 2008-09-25 Panacea Biotec Ltd. Novel compositions for topical delivery
WO2009070564A2 (en) * 2007-11-27 2009-06-04 Macrochem Corporation Compositions and methods for prevention of infection in transcutaneous osseointegrated implants
WO2012174373A1 (en) * 2011-06-16 2012-12-20 Dipexium Pharmaceuticals Methods of treating and inhibiting pathogens with resistance-mechanisms
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100221195A1 (en) 2006-11-14 2010-09-02 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20100036000A1 (en) 2008-07-21 2010-02-11 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders

Also Published As

Publication number Publication date
KR20150043286A (ko) 2015-04-22
ES2599395T3 (es) 2017-02-01
EP2858721A4 (en) 2015-12-09
AU2013274561B2 (en) 2015-09-10
HRP20161440T1 (hr) 2016-12-16
LT2858721T (lt) 2016-12-12
SMT201600411B (it) 2017-01-10
EP2858721A1 (en) 2015-04-15
NZ703176A (en) 2015-08-28
EA028002B1 (ru) 2017-09-29
RS55286B1 (sr) 2017-03-31
BR112014030993A2 (pt) 2017-06-27
AU2013274561A1 (en) 2015-01-22
CA2876668C (en) 2017-12-05
PL2858721T3 (pl) 2017-02-28
US20140038882A1 (en) 2014-02-06
IL236151A0 (en) 2015-01-29
CA2876668A1 (en) 2013-12-19
EA201492280A1 (ru) 2015-05-29
US8530409B1 (en) 2013-09-10
DK2858721T3 (en) 2016-11-28
MX345263B (es) 2017-01-23
ZA201500117B (en) 2016-10-26
SG11201408055PA (en) 2015-01-29
JP5876191B2 (ja) 2016-03-02
CN104602762A (zh) 2015-05-06
IL236151A (en) 2016-06-30
WO2013188286A1 (en) 2013-12-19
PT2858721T (pt) 2016-11-17
HUE030665T2 (en) 2017-05-29
SI2858721T1 (sl) 2017-01-31
HK1210078A1 (en) 2016-04-15
MX2014015199A (es) 2015-08-14
EP2858721B1 (en) 2016-08-17
CN104602762B (zh) 2017-04-05
CY1118277T1 (el) 2017-06-28
JP2015521599A (ja) 2015-07-30

Similar Documents

Publication Publication Date Title
US8871716B2 (en) Use of antimicrobial peptides in regeneration of skin cells
EP2915541B1 (en) Vesicles which include epidermal growth factor and compositions that contain same
US20080020983A1 (en) Peptides with antioxidant and antimicrobial properties
KR101622524B1 (ko) 안정한 펙시가난 제제
KR102158036B1 (ko) Pseudin-2 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
DE60125809T2 (de) Diastereomere peptide und diese umfassende arzneimittel
KR20220141946A (ko) 태평양굴에서 유래한 항균 펩타이드 및 이의 용도
KR101627455B1 (ko) 항균활성을 가지는 키메라 펩타이드 및 이를 함유하는 항균용 조성물
US20180289656A1 (en) Compositions and methods to treat urinary tract infections
JP7440126B2 (ja) 新生物性病変治療用ペプチド含有組成物
US11117931B2 (en) Antimicrobial peptide derived from Hp1404 peptide and uses thereof
KR102039400B1 (ko) mBjAMP1 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
EP3496740B1 (en) A combination of antimicrobial peptides and antibiotic drugs for treating diseases
KR20220099306A (ko) Hylin a1 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
HK1210078B (en) Stable pexiganan formulation
KR102887687B1 (ko) 식용유지를 포함하는 봉독 조성물
KR102608336B1 (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
A302 Request for accelerated examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20190513

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20190513